A dose-response study of the effect of flutamide on benign prostatic hyperplasia: Results of a multicenter study

Urology

Volumn 47, Issue 4, 1996, Pages 497-504

  Narayan, Perinchery ^a   Trachtenberg, John ^b   Lepor, Herbert ^b   Debruyne, F M J ^b   Tewari, Ashutosh ^b   Stone, Nelson ^b   Das, Sakti ^b   Jimenez Cruz, J F ^b   Shearer, Robert ^b   Klimberg, Ira ^b   Schellhammer, Paul F ^b   Costello, Anthony J ^b  

^a UNIVERSITY OF FLORIDA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

FLUTAMIDE; PLACEBO; PROSTATE SPECIFIC ANTIGEN;

ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOSE RESPONSE; DRUG EFFECT; DRUG SAFETY; GYNECOMASTIA; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; RANDOMIZED CONTROLLED TRIAL; RESIDUAL URINE; STATISTICAL ANALYSIS; URINE VOLUME;

EID: 9344269894     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(99)80484-1     Document Type: Article

References (20)

1. Isaack JT: Importance of the natural history of benign prostatic hyperplasia in the evaluation of pharmacologic intervention. Prostate 3: 1-7, 1990.
2. Holtgrewe HL, Mebust WK, Dowd JB, Cockett AT, Peters PC, and Proctor C: Transurethral prostatectomy: practice aspects of the dominant operation in American urology. J Urol 141: 248-253, 1989.
3. Abrams P: In support of pressure-flow studies for evaluating men with lower urinary tract symptoms (editorial). Urology 44: 153-155, 1994.
4. Caine M, Perlberg S, and Gordon R: The treatment of benign prostatic hypertrophy with flutamide (SCH: 13521): a placebo-controlled study. J Urol 114: 564-568, 1975.
5. Stone NN: Flutamide in treatment of benign prostatic hypertrophy. Urology 34: 64-68, 1989.
6. Stone NN, and Clejan SJ: Response of prostate volume, prostate-specific antigen, and testosterone to flutamide in men with benign prostatic hyperplasia. J Androl 12: 376-380, 1991.
7. Moore RA: The evolution and involution of the prostate gland. Am J Pathol 12: 599-624, 1936.
8. Moore RA: Benign hypertrophy of the prostate: a morphological study. J Urol 50: 680-710, 1943.
9. Schroeder FH, Westerhof M, Bosch RJ, and Kurth KH: Benign prostatic hyperplasia treated by castration or the LH-RH analogue buserelin: a report on 6 cases. Eur Urol 12: 318-321, 1986.
10. Peters CA, and Walsh PC: The effect of nafarelin acetate, a luteinizing-hormone-releasing hormone agonist, on benign prostatic hyperplasia. N Engl J Med 317: 599-604, 1987.
11. Bosch RJ, Griffiths DJ, Blom JH, and Schroeder FH: Treatment of benign prostatic hyperplasia by androgen deprivation: effects on prostate size and urodynamic parameters. J Urol 141: 68-72, 1989.
12. Neri R, Florance K, Koziol P, and Van Cleave S: A biological profile of a nonsteroidal antiandrogen, SCH 13521 (4′-nitro-3′-trifluromethyl-isobutyranilide). Endocrinology 91: 427-437, 1972.
13. Neri RO, and Monahan M: Effects of a novel non-steroidal antiandrogen on canine prostatic hyperplasia. Invest Urol 10: 123-130, 1972.
14. Neri RO, Monahan MD, Meyer JG, Afonso BA, and Tabachnick IA: Biological studies of an anti-androgen (SH 714). Eur J Pharmacol 1: 438-444, 1967.
15. Huggins C, and Stevens RA: The effect of castration on benign hypertrophy of the prostate in man. J Urol 43: 705-714, 1940.
16. Tewari A, Shinohara K, and Narayan P: Transition zone volume and transition zone ratio: predictor of uroflow response to finasteride therapy in benign prostatic hyperplasia patients. Urology 45: 258-265, 1995.
17. Lepor H, and Machi G: Comparison of AUA symptom index in unselected males and females between fifty-five and seventy-nine years of age. Urology 42: 36-41, 1993.
18. Wendel EF, Brannen GE, Putong PB, and Grayhack JT: The effect of orchiectomy and estrogens in benign prostatic hyperplasia. J Urol 108: 116-119, 1972.
19. Lepor H, and Laddu A: Terazosin in the treatment of benign prostatic hyperplasia: the United States experience. Br J Urol 70: 2-9, 1992.
20. Stoner E, Round E, Ferguson D, and Gormley GJ: Clinical experience of the detection of prostate cancer in patients with benign prostate hyperplasia treated with finasteride. The Finasteride Study Group. J Urol 151: 1296-1300, 1994.